IMMOBILISATION OF POLYPEPTIDES BY IRRADIATION
    21.
    发明申请
    IMMOBILISATION OF POLYPEPTIDES BY IRRADIATION 审中-公开
    通过辐射消除多糖

    公开(公告)号:US20100216969A1

    公开(公告)日:2010-08-26

    申请号:US11993168

    申请日:2006-06-27

    IPC分类号: C07K7/50 C07K1/00 C07K7/06

    CPC分类号: G01N33/54353 C07K17/06

    摘要: The present invention relates generally to methods and carriers for cross-linking or immobilising biomolecules such as polypeptides. In particular, the present invention relates to methods and carriers useful for coupling a polypeptide to a carrier via at least one disulphide bond. The carrier coupled to the biomolecules has applications in the fields of e.g. molecular biology, biochemistry, pharmacology, and medical diagnostic technology.

    摘要翻译: 本发明一般涉及用于交联或固定生物分子如多肽的方法和载体。 特别地,本发明涉及用于通过至少一个二硫键将多肽偶联到载体上的方法和载体。 偶联到生物分子的载体具有例如以下领域的应用。 分子生物学,生物化学,药理学和医学诊断技术。

    CYCLOSPORIN ANALOGUES
    22.
    发明申请
    CYCLOSPORIN ANALOGUES 有权
    环磷酰胺类似物

    公开(公告)号:US20100209390A1

    公开(公告)日:2010-08-19

    申请号:US12708671

    申请日:2010-02-19

    CPC分类号: C07K7/645 A61K38/00

    摘要: The present invention provides cyclosporin analogues of formula I, and compositions comprising these compounds, as well as processes for their preparation, intermediates in their synthesis, and methods of use thereof for prevention of organ transplantation rejection, the treatment of immune disorders and inflammation, and treatment of viral (particularly hepatitis C viral) infection.

    摘要翻译: 本发明提供式I的环孢菌素类似物,以及包含这些化合物的组合物,及其制备方法,其合成中的中间体及其用于预防器官移植排斥反应,免疫疾病和炎症的治疗的方法和 治疗病毒(特别是丙型肝炎病毒)感染。

    CYCLISED ALPHA-CONOTOXIN PEPTIDES
    23.
    发明申请

    公开(公告)号:US20100120670A1

    公开(公告)日:2010-05-13

    申请号:US12297110

    申请日:2007-04-03

    CPC分类号: A61K38/17 A61K38/12

    摘要: This invention relates to an oral or enteral pharmaceutical preparation comprising at least one synthetically cyclised alpha-conotoxin peptide having an amide cyclised backbone such that the peptide has no free N- or C-terminus, said peptide having the ability to inhibit a nicotinic acetylcholine receptor and comprising four cysteine residues bonded in pairs to form two disulfide bonds, wherein the N-terminus of the corresponding linear/non-cyclised conotoxin peptide is linked to the C-terminus by a peptide linker, in a vehicle which is pharmaceutically suitable for oral or enteral administration.

    摘要翻译: 本发明涉及口服或肠内药物制剂,其包含至少一种具有酰胺环化主链的合成环化的α-芋螺毒素肽,使得肽不具有游离的N-或C-末端,所述肽具有抑制烟碱乙酰胆碱受体的能力 并且包含成对结合以形成两个二硫键的四个半胱氨酸残基,其中相应的线性/非环化的芋螺毒素肽的N-末端通过肽接头在C末端连接,其药学上适用于口服 或肠内管理。

    STABILIZED MAML PEPTIDES AND USES THEREOF
    24.
    发明申请
    STABILIZED MAML PEPTIDES AND USES THEREOF 有权
    稳定的乳腺肽及其用途

    公开(公告)号:US20100081611A1

    公开(公告)日:2010-04-01

    申请号:US12478504

    申请日:2009-06-04

    CPC分类号: C07K14/47 A61K38/00

    摘要: Stably cross-linked a polypeptides related to human MAML are described. These cross-linked polypeptides contain at least two modified amino acids that together form an internal cross-link or tether that can help to stabilize the alpha-helical secondary structure that is thought to be important for binding of MAML peptides to the Notch transcription complex, a complex that includes ICN and CSL.

    摘要翻译: 描述了稳定交联的与人MAML相关的多肽。 这些交联的多肽含有至少两个修饰的氨基酸,它们一起形成可以有助于稳定被认为对MAML肽与Notch转录复合物的结合重要的α-螺旋二级结构的内部交联或系链, 一个包含ICN和CSL的复合体。

    DEUTERIUM-ENRICHED OCTREOTIDE
    25.
    发明申请
    DEUTERIUM-ENRICHED OCTREOTIDE 审中-公开
    脱氧核糖核酸(DEUTERIUM-ENRICHED OCTREOTIDE)

    公开(公告)号:US20090082259A1

    公开(公告)日:2009-03-26

    申请号:US12196914

    申请日:2008-08-22

    IPC分类号: A61K38/12 C07K7/50 A61P43/00

    CPC分类号: A61K38/12

    摘要: The present application describes deuterium-enriched octreotide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

    摘要翻译: 本申请描述了富含氘的奥曲肽,其药学上可接受的盐形式,以及使用其的治疗方法。

    Novel Imaging Agents for Cancer
    26.
    发明申请
    Novel Imaging Agents for Cancer 审中-公开
    癌症新型成像剂

    公开(公告)号:US20080279771A1

    公开(公告)日:2008-11-13

    申请号:US12091804

    申请日:2006-10-30

    摘要: A novel imaging agent is described which comprises a semaphorin moiety and an imaging moiety. The novel imaging agent of the invention may be used in the diagnostic imaging of cancer and in particular, for targeting angiogenesis or metaplasia. Further aspects of the present invention presented herein include a method for the preparation of the imaging agent, a pharmaceutical composition comprising the imaging agent of the invention and a kit for the preparation of said pharmaceutical.

    摘要翻译: 描述了一种包含信号素部分和成像部分的新型成像剂。 本发明的新型成像剂可用于癌症的诊断成像,特别是用于靶向血管生成或化生。 本文提供的本发明的其它方面包括制备显像剂的方法,包含本发明的成像剂的药物组合物和用于制备所述药物的试剂盒。

    Treating Cancer
    27.
    发明申请
    Treating Cancer 有权
    治疗癌症

    公开(公告)号:US20080247999A1

    公开(公告)日:2008-10-09

    申请号:US11570743

    申请日:2005-06-14

    摘要: The present invention provides a peptide comprising an amino acid sequence that is part of the amino acid sequence of CDK4 protein, or homologous to part of the amino acid sequence of CDK4 protein, which peptide is cytotoxic to, and/or inhibiting to the growth of, a cancer cell and/or stimulating to the growth of a non-cancerous cell and/or a control cell. Methods of identifying such peptides and medical uses of such peptides are also disclosed.

    摘要翻译: 本发明提供了一种肽,其包含作为CDK4蛋白的氨基酸序列的一部分的氨基酸序列,或与CDK4蛋白的氨基酸序列的一部分同源的肽,该肽是细胞毒性的和/或抑制的 ,癌细胞和/或刺激非癌细胞和/或对照细胞的生长。 还公开了鉴定这些肽的方法和这种肽的医疗用途。